Using a novel approach, researchers have discovered a genetic variant that may contribute to the muscle pain and weakness experienced by some statin users, according to a study published in Nature August 28. Under statin-treated conditions, the variant affects expression of the gene for glycine amidinotransferase (GATM), which controls the synthesis rate of creatine, a molecule muscles use for energy.
“The authors used a really unique approach for trying to understand why some people might respond differently [to statins],” said Deepak Voora, a physician-scientist studying pharmacogenetics at Duke University, who was not involved in the research. “That approach will have implications for studying other drugs.”
Share this article
Read the full, original story here: Gene a Pain for Statin Users
